title: Localized childhood vulval pemphigoid treated with tacrolimus ointment.
abstract: BACKGROUND
  Localized vulval childhood pemphigoid is a rare variant within the pemphigoid group. Although its prognosis seems favorable, the best therapeutic strategy remains unclear.
  
  
  METHODS
  We here describe the case of an 8-year-old girl presenting with a 5-year history of relapsing vulval pain and lesions suggestive of lichen sclerosus. Clinical features, light microscopy and direct immunofluorescence microscopy were consistent with vulval cicatricial pemphigoid, although the autoantigen(s) involved could not be characterized. Her disease responded to treatment with topical tacrolimus ointment 0.1% within 3 months without any evidence for disease activity, except for slight residual scarring. After 12 months, her treatment was stopped without relapse.
  
  
  CONCLUSIONS
  This observation suggests that in this rare immune-mediated blistering disease topical tacrolimus is an interesting therapeutic option without the adverse effects associated with topical steroids.
authors.affiliation: Department of Dermatology, University Hospital, Geneva, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Lebeau
authors.forename: C
authors.initials: C
authors.lastname: Mainetti
authors.forename: I
authors.initials: I
authors.lastname: Masouyé
authors.forename: J-H
authors.initials: JH
authors.lastname: Saurat
authors.forename: L
authors.initials: L
authors.lastname: Borradori
mesh_terms: D000287:Administration, Topical; D002648:Child; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009824:Ointments; D010391:Pemphigoid, Bullous / Q000188:drug therapy* / Q000473:pathology; D055502:Secondary Prevention; D016559:Tacrolimus / Q000627:therapeutic use*; D014845:Vulvar Diseases / Q000188:drug therapy* / Q000473:pathology
chemical_list: D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus